Page last updated: 2024-10-23

benzothiazide and Experimental Pneumococcal Meningitis

benzothiazide has been researched along with Experimental Pneumococcal Meningitis in 2 studies

benzothiazide: structure
benzthiazide : 7-Sulfamoyl-1,2,4-benzothiadiazine 1,1-dioxide in which the hydrogen at position 6 is substituted by chlorine and that at position 3 is substituted by a benzylsulfanylmethyl group. A diuretic, it is used to treat hypertension and edema.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Hathaway, LJ1
Schmidt, F1
Kakar, N1
Meyer, TC1
Depke, M1
Masouris, I1
Burchhardt, G1
Gómez-Mejia, A1
Dhople, V1
Håvarstein, LS1
Sun, Z1
Moritz, RL1
Völker, U1
Koedel, U1
Hammerschmidt, S1

Other Studies

2 other studies available for benzothiazide and Experimental Pneumococcal Meningitis

ArticleYear
New Virulence Factors Identified in Pneumococcal Meningitis.
    Trends in microbiology, 2019, Volume: 27, Issue:11

    Topics: Humans; Meningitis, Pneumococcal; Oligopeptides; Proteomics; Regulon; Virulence Factors

2019
In vivo proteomics identifies the competence regulon and AliB oligopeptide transporter as pathogenic factors in pneumococcal meningitis.
    PLoS pathogens, 2019, Volume: 15, Issue:7

    Topics: Animals; Bacterial Proteins; Carrier Proteins; Genes, Bacterial; Host Microbial Interactions; Humans

2019